NEWS
Follow us on twitter: @csjmagazine
New insulin injection and infusion recommendations for clinicians
The medical journal Mayo Clinic Proceedings has published new insulin delivery recommendations for healthcare professionals caring for insulin-using patients, including the results from the largest injection technique survey ever performed for people with diabetes. Three articles appeared in the September print issue of the publication – with new research showing that many patients with diabetes are using insulin incorrectly and not getting the maximum benefit from this life-saving medication. Proper injection and infusion technique is critical to insulin’s consistent action and may be as important as the medication or diet and activity. These findings provide a clear roadmap for better clinical management of insulin use for people with diabetes and for their health care providers. The analysis of this landmark injection technique survey is the result of a BD (Becton, Dickinson and Company) sponsored international workshop known as the Forum for Injection Technique & Therapy Expert Recommendations (FITTER). This international congress included 183 diabetes experts from 54 countries and took place October 2015 in Rome. Two of the papers published in Mayo Clinic Proceedings address the key findings from this injection technique survey and a third paper presents the new insulin delivery recommendations, intended to help shape local and regional injection guidelines around the world. Dr Kenneth Strauss, co-author and medical director, BD Europe stated: “FITTER and these publications set new standards for insulin delivery. Tools are embedded in these publications, which will allow patients and professionals to quickly translate them into everyday practice. If these recommendations become routine practice, we should soon see
the improved outcomes that come from optimised insulin delivery.” Key findings of the insulin injection technique survey included: l Many patients taking insulin are using needles that are longer and thicker than recommended, and are reusing the needles frequently.
l One-third of those taking insulin have nodules or bumps in the fat tissue at their injection sites (a condition known as lipohypertrophy, or lipos). This is associated with incorrect rotation of injection sites and is also problematic with insulin infused via pumps.
l If patients inject into lipos, the absorption of insulin is blunted and highly variable. This may cause patients to react by injecting more insulin, which puts them at risk of unexpected glucose swings and dangerous hypoglycemia.
l Despite using more insulin, patients with lipos have worse glucose control, increasing their risk for eye, kidney and nerve complications.
The third publication, ‘New Recommendations for Insulin Delivery’ is based on these survey findings as analysed by participants of the FITTER international congress. The new recommendations include: l Use the shortest available pen needle (currently 4mm) or syringe needle (currently 6mm) for all injecting patients, regardless of age, sex or body size.
l The shortest needle length is less painful, has higher patient acceptance and gives comparable glucose control.
l By contrast, excessively long needles increase a patient’s risk of intramuscular injections, which can accelerate insulin
uptake and action, increasing glucose variability and risk of hypoglycemia.
l Correct rotation of injection sites can reduce the frequency of lipohypertrophy. Such reductions should improve glycaemic control and clinical outcomes, reduce insulin consumption and thereby lower health care costs.
l Limit use of pen needles and syringes to one-time, as reusing needles is not an optimal injection practice because they are no longer sterile after use.
The new FITTER recommendations also contain important sections dealing with optimal insulin pump and infusion set guidance, as well as recommendations for use of safety-engineered injection devices for people who give injections, such as healthcare workers. In conclusion, adherence to these recommendations may lead to better injection and infusion experience for patients, safer injections by HCWs, and improved glucose control, which reduces the risk of long-term complications and saves health care funds. To review all of the studies in more detail and to view the “Golden Rules”, please visit:
mayoclinicproceedings.org or
http://www.fitter4diabetes.com.
Register at:
www.clinicalservicesjournal.com to receive full access to our online content, regular email newsletters on healthcare news and innovation and digital copies of CSJ.
Tracking T34 syringe drivers helps NHS Forth Valley save £50,000
Tracking the locations of their McKinley T34 syringe drivers with Harland Simon’s RFID Discovery has enabled NHS Forth Valley to improve utilisation of these specialist pumps and avoid a capital cost of £50,000 to purchase additional devices.
When a recent proposal suggested they buy an additional 50 T34s at around £1,000 each to cope with demand, Bryan Hynd, Head of Medical Physics at NHS Forth Valley, decided instead to track all available devices with the active RFID Discovery system. According to purchasing records the hospital should own a total of 40 T34s, but at one point only 4 of them could be found. Locating pumps had been an on-going challenge, which often meant that devices were in short supply. Since tagging the T34s, a total of 22 have
over the years, but nothing ever worked. Since we have started tracking the T34s in March, we have always had sufficient pumps on the shelf.” Palliative care nurses used to spend a lot
been found. Bryan comments: “Tracking devices means that now they are shared better between departments and we find that 6 or 7 of them are always available at any one time.” Sandra Campbell, Macmillan Nurse Consultant for Cancer & Palliative Care, explains: “We have tried all sorts of systems
10 I
WWW.CLINICALSERVICESJOURNAL.COM
of time trying to locate the devices. Now they can access a simple on-line search screen and see how many of these pumps are in each of the areas. T34s are very small syringe drivers, designed for administering palliative care medicines and can be placed under a mattress to be less intrusive. Sandra comments: “Before implementing the tracking there were occasions when we’ve had to use larger infusion pumps, which goes against our ethos of de-medicalising end-of-life care.” Tracking the pumps has also made it much easier to locate the devices for maintenance.
FEBRUARY 2017
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64
